Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Newbouldia laevis root extract is a botanical preparation derived from the roots of the Newbouldia laevis tree, a species native to tropical Africa and widely used in traditional Nigerian medicine. The extract is traditionally employed to treat a variety of ailments, including pain, inflammation, epilepsy, and convulsions. Scientific investigations, such as those conducted in Wistar rats, have corroborated these uses, demonstrating significant analgesic, anti-inflammatory, and anticonvulsant activities. These effects are attributed to a diverse array of phytochemicals present in the root, including alkaloids, flavonoids, tannins, and quinones. While it is a staple of ethnomedicine, it has not yet undergone formal clinical development for regulatory approval as a pharmaceutical drug.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on newbouldia laevis root extract.